- Home
- TXMD vs IMCC Comparison
TXMD vs IMCC Comparison
Compare TXMD & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- IMCC
- Stock Information
- Founded
- TXMD 2008
- IMCC 1980
- Country
- TXMD United States
- IMCC Israel
- Employees
- TXMD N/A
- IMCC N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- TXMD Health Care
- IMCC Health Care
- Exchange
- TXMD Nasdaq
- IMCC Nasdaq
- Market Cap
- TXMD 13.5M
- IMCC 12.0M
- IPO Year
- TXMD N/A
- IMCC N/A
- Fundamental
- Price
- TXMD $1.17
- IMCC $2.95
- Analyst Decision
- TXMD
- IMCC
- Analyst Count
- TXMD 0
- IMCC 0
- Target Price
- TXMD N/A
- IMCC N/A
- AVG Volume (30 Days)
- TXMD 35.2K
- IMCC 151.3K
- Earning Date
- TXMD 08-11-2025
- IMCC 08-13-2025
- Dividend Yield
- TXMD N/A
- IMCC N/A
- EPS Growth
- TXMD N/A
- IMCC N/A
- EPS
- TXMD N/A
- IMCC N/A
- Revenue
- TXMD $1,841,000.00
- IMCC $37,894,737.00
- Revenue This Year
- TXMD $427.09
- IMCC $47.12
- Revenue Next Year
- TXMD N/A
- IMCC $12.83
- P/E Ratio
- TXMD N/A
- IMCC N/A
- Revenue Growth
- TXMD 53.55
- IMCC 12.68
- 52 Week Low
- TXMD $0.70
- IMCC $1.29
- 52 Week High
- TXMD $2.44
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- TXMD 47.76
- IMCC 51.60
- Support Level
- TXMD $1.13
- IMCC $2.37
- Resistance Level
- TXMD $1.24
- IMCC $3.75
- Average True Range (ATR)
- TXMD 0.09
- IMCC 0.38
- MACD
- TXMD 0.01
- IMCC 0.03
- Stochastic Oscillator
- TXMD 73.12
- IMCC 41.99
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.